[Mycoses following destructive processes of respiratory organs].
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D000908:Antibodies, Fungal / Q000032:analysis; D001228:Aspergillosis / Q000150:complications / Q000209:etiology; D002175:Candida; D002177:Candidiasis / Q000175:diagnosis; D003428:Cross Infection; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D008172:Lung Diseases, Fungal / Q000175:diagnosis / Q000209:etiology*; D012140:Respiratory Tract Diseases / Q000150:complications*; D013183:Sputum / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000150:complications
D000900:Anti-Bacterial Agents; D000908:Antibodies, Fungal
Pilzerkrankungen im Gefolge destruierender Prozesse der Atmungsorgane